论文部分内容阅读
本文对62例肺癌患者进行红细胞免疫功能及T淋巴细胞亚群测定，并与20例正常人对照，结果显示：肺癌组红细胞膜C3b受体活性（RBC－C3bRR）；CD3+、CD4+、CD4+／CD8+比值均低于正常人（P＜0.05～0.01），红细胞膜吸附免疫复合物（RBC－ICR）、CD8+均高于正常人（P＜0.05～0.01），因此认为红细胞免疫功能及T淋巴细胞亚群测定对肺癌的诊断、治疗及预后有一定价值。
In this paper, 62 cases of lung cancer patients were tested for red blood cell immune function and T lymphocyte subsets, and compared with 20 normal subjects. The results showed that: RBC membrane C3b receptor activity (RBC-C3bRR) in lung cancer group; CD3+, CD4+, CD4+/CD8+ The ratios were all lower than normal (P<0.05-0.01). RBC-ICR and CD8+ were all higher than those in normal subjects (P<0.05-0.01). Therefore, red blood cell immune function and T lymphocyte subsets were considered. Population determination has some value in the diagnosis, treatment and prognosis of lung cancer.